28.8 C
Vientiane
Tuesday, September 9, 2025
spot_img
Home Blog Page 349

Government-Private Sector-Civil Society Unite with Global Experts to Accelerate Green Transition Propelling Thailand Toward Low-Carbon Society

Driving Two Key Agendas to Strengthen Global Competitiveness


BANGKOK, THAILAND – Media OutReach Newswire – 4 August 2025 SCG organized the ESG Symposium 2025 under the concept “GREEN BREAKTHROUGH AMID THE PERFECT STORM” at SCG Headquarters, Bangkok. The event drew over 300 participants comprising key stakeholders driving Green Transition from government, private sector, civil society, and world-class experts who gathered to brainstorm and advance crucial collaboration for transitioning Thailand and the ASEAN region toward a fair and sustainable low-carbon society.

Leading international speakers sharing perspectives and approaches for transitioning to sustainability at the ESG Symposium 2025 at SCG Headquarters, Bangkok, Thailand
Leading international speakers sharing perspectives and approaches for transitioning to sustainability at the ESG Symposium 2025 at SCG Headquarters, Bangkok, Thailand

The symposium facilitated policy and practical exchanges on two fundamental agendas that serve as critical keys to the transition, working together to reach conclusions for driving the low-carbon society forward: 1) Energy Transition aimed at elevating energy systems to align with Net Zero targets, and 2) Just Transition for SMEs creating opportunities for small and medium enterprises to genuinely access ESG mechanisms.

The forum was honored by global leaders including Mr. Koji Sato – President and CEO, Toyota Motor Corporation, Mr. David McLachlan-Karr – Regional Director, UN Development Coordination Office (DCO), Asia-Pacific, and researchers from MIT including Dr. Sai Ravela – Principal Research Scientist, Earth, Atmospheric and Planetary Sciences (EAPS), MIT and Prof. Miho Mazereeuw – Director of MIT Climate Mission and Director of Urban Risk Lab, MIT, alongside Dr. ​Sethaput Suthiwartnarueput, Governor of the Bank of Thailand, who presented approaches for adaptation, building resilience, and enhancing Thailand’s long-term competitiveness.

ESG Symposium 2025 represents a collaborative platform where all sectors join forces to accelerate the creation of a sustainable regional future, connecting environmental objectives with economic opportunities and preparing ASEAN to address a rapidly changing world.

Hashtag: #esgsymposium2025 #GreenBreakthroughAmidThePerfectStorm

The issuer is solely responsible for the content of this announcement.

Alphamab Oncology Announces IND Application for Innovative PD-L1/αvβ6 Bispecific ADC JSKN022 was Officially Accepted by CDE

SUZHOU, China, Aug. 4, 2025 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN022, an independently developed innovative bispecific antibody-drug conjugate (ADC) targeting PD-L1 and integrin αvβ6, has been officially accepted by the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA). The Company plans to initiate a first-in-human (FIH) clinical study of JSKN022 for the treatment of advanced malignant solid tumors.

JSKN022 is an innovative bispecific ADC developed in-house with Alphamab’s proprietary glycan-specific conjugation platform. The molecule simultaneously targets and binds to both PD-L1 and integrin αvβ6 on the surface of tumor cells. After binding to either target, JSKN022 enters the lysosome through target-mediated endocytosis. The cleavable linker is specifically hydrolyzed by proteolytic enzymes such as cathepsin B, releasing cytotoxic topoisomerase I inhibitor (T01), which then induces apoptosis of PD-L1 and/or integrin αvβ6 positive tumor cells. In addition, the inhibitor can penetrate the cell membrane and enter the antigen-negative tumor cells to exert bystander effects. These combined effects can effectively inhibit the growth of tumor cells.

At present, no ADC targeting integrin αvβ6 or PD-L1 has been approved for marketing worldwide, with all related investigational candidates remaining in clinical development stages. Preclinical data demonstrate that JSKN022 exhibits potent antitumor activity in both in vitro and in vivo models against tumor cells expressing integrin αvβ6 and/or PD-L1. JSKN022 will potentially bring in novelty in the therapeutic approach for cancers that are refractory or resistant to PD-1/PD-L1 inhibitors, including non-small cell lung cancer, head and neck squamous cell carcinoma, and colorectal cancer.

This Phase I clinical study will evaluate the safety, tolerability, pharmacokinetics (PK)/pharmacodynamics (PD), and antitumor activity of JSKN022 in patients with advanced malignant solid tumors who have failed standard therapies, and determine the maximum tolerated dose (MTD) and/or recommended Phase II dose (RP2D).

About JSKN022
JSKN022 is a first-in-class ADC targeting both PD-L1 and integrin αvβ6. Based on independently developed Envafolimab, Alphamab integrates immuno-oncology (IO) mechanisms with ADC approaches. This novel drug molecule utilizes glycan-specific conjugation technology to enhance both stability and homogeneity. The topoisomerase I inhibitor T01 is site-specifically conjugated to antibodies via a cleavable linker, enhancing therapeutic efficacy. JSKN022 is expected to provide a novel therapeutic option for cancers that are refractory or resistant to PD-1/PD-L1 inhibitors. The IND application for the first-in-human clinical study of JSKN022 for the treatment of advanced malignant solid tumors has been accepted by CDE.

About Alphamab Oncology
Alphamab Oncology is an innovative biopharmaceutical company focusing on oncology therapeutics. On December 12, 2019, the Company was successfully listed on the Main Board of the Hong Kong Stock Exchange, trading under the stock code 9966.

By leveraging its proprietary core technology platforms including single-domain antibodies, bispecific antibodies, glycan-specific conjugation, linker-payload, dual-payload antibody conjugation, and subcutaneous high concentration formulation for biologics, the Company has established a product portfolio with differentiated innovation and global competitiveness, covering cutting-edge areas such as antibody-drug conjugates (ADCs), bispecific antibodies, and single-domain antibodies.

The Company has one product approved for marketing (Envafolimab, the world’s first subcutaneously injectable PD-(L)1 inhibitor), which has made a significant breakthrough in the convenience and accessibility of cancer treatment. Additionally, the Company has multiple bispecific antibodies and bispecific ADCs in clinical stage, while rapidly advancing the preclinical pipeline prioritizing bispecific ADCs and dual-payload ADCs. Multiple strategic collaborations based on innovative products or technology platforms have been established with partners such as CSPC, ArriVent, and Glenmark.

Our overarching mission is to make cancer manageable and curable by addressing unmet clinical needs in oncology. Alphamab Oncology is continuously dedicated to the development of effective, safe, and globally competitive anti-tumor drugs, delivering China-innovated cancer therapies to benefit patients worldwide.

 

Omni HR Acquires Singapore-Based MajuHR, Strengthening Its Position in Asia’s HR Tech Market

SINGAPORE, Aug. 4, 2025 /PRNewswire/ — People Intelligence Singapore Pte. Ltd. (“Omni HR”) today announced the acquisition of MajuHR, a Singapore-based HR software company, for an undisclosed amount. This marks Omni’s first acquisition and a strategic step toward consolidating Asia’s fragmented HR technology landscape.

Strong growth drives expansion

Singapore-based Omni HR provides cloud-based HR and payroll solutions across 15+ Asian markets, offering automated workflows alongside local compliance capabilities. The company’s $7.4 million funding round in 2024 and rapid customer growth set the stage for its first acquisition.

MajuHR is a pioneer in omnichannel-native HR software in Southeast Asia, letting employees request time off or check their payslips through a simple WhatsApp message—the way many Asian teams already communicate. By integrating MajuHR’s chat-native DNA with Omni HR’s multi-country capabilities, the combined platform will deliver more intuitive HR experiences tailored to how modern Asian teams operate.

Market demands modern solutions

The deal reflects growing demand in Asia’s $6.4 billion HR software market for platforms that actually understand how business gets done in the region, combining sophisticated automation with regional compliance expertise—capabilities that many local providers have been slow to develop.

“At Omni HR, our focus has always been on bringing automation and flexible workflows to modern teams operating across borders in Asia. The acquisition of MajuHR allows us to deepen our product capabilities and broaden our client portfolio,” said Brian Ip, Founder & CEO of Omni HR.

“Omni’s track record in multi-country employee management across Asia is second to none. We’re thrilled to bring our chat-native DNA under the Omni banner and collectively unlock a more seamless, data-rich experience for HR and Finance leaders across the region,” said Roshan Ravishankar, Co-founder of MajuHR.

MajuHR’s customer base will transition to Omni HR’s platform, adding to the company’s growing portfolio of modern, tech-forward businesses across the region.

The acquisition positions Omni HR as a key player among emerging Asian HR technology companies that are developing platforms competitive with global software providers while maintaining deep local market knowledge.

Looking ahead, Omni HR plans to continue investing in deeper localisation. The company is also exploring additional partnerships and product extensions to better serve growing mid-market and enterprise clients across Asia. With the acquisition of MajuHR, Omni lays the groundwork for future expansion via both product development and strategic M&A.

About Omni HR: Founded in 2021, Omni HR provides cloud-based HR and payroll software for companies scaling across Asia. The Singapore-based company offers automated workflows, multi-country payroll processing, performance management, and employee onboarding across all major Asian markets. Backed by leading investors including Picus Capital and Alpha JWC Ventures, Omni HR has raised $9.8 million in funding to-date. For more information, visit www.omnihr.co.

About MajuHR: MajuHR is a Singapore-based, omnichannel chat-native HR platform used by thousands across Southeast Asia to manage full-suite HR through consumer chat apps. Founded by Charlie Angriawan and Roshan Ravishankar, with founding team members Dipansh Bhatt and Madhusudan Murali.

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Groundbreaking Pulmonary Therapeutics

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies

CAMBRIDGE, Mass. and BIRMINGHAM, Ala. and RAICHUR, India, Aug. 4, 2025 /PRNewswire/ — Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic financing round led by Shilpa Medicare Limited (BSE: 524742) (NSE: SHILPAMED), a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufacturing and biotechnology innovation.

Through this collaboration, Shilpa Biologics, the biologics arm of Shilpa Medicare, will become Alveolus Bio’s exclusive global development and manufacturing partner. This partnership propels Alveolus Bio’s live biotherapeutics and small molecule platform towards Phase 2 and first-in-human clinical trials, with a lead asset for COPD progressing rapidly.

Shilpa Medicare brings deep experience in drug discovery, development, and manufacturing, along with strong regulatory capabilities. Their investment and strategic involvement will accelerate the clinical advancement of Alveolus Bio’s resMIT (respiratory microbiota-based inhaled therapeutics) platform. This novel platform enables targeted delivery of inhaled therapies to deep lung regions, addressing unmet needs in diseases such as COPD, Bronchopulmonary Dysplasia (BPD), and Pulmonary Fibrosis.

“Securing Shilpa as our lead investor is a transformative step,” said Gaurav Mehta, CEO of Alveolus Bio. “Their global pharmaceutical leadership aligns perfectly with our vision to redefine how lung diseases are treated.”

“Alveolus Bio’s breakthrough science is poised to transform respiratory care. Through this strategic partnership with Shilpa, we combine disruptive biotech innovation with world-class commercialization, bringing life-changing therapies faster to the market,” said Dr. C. Vivek Lal, Founder and CSO, Alveolus Bio.

“Shilpa has always focused on enabling breakthrough biologics,” said Vishnukant Bhutada, Managing Director, Shilpa Medicare. “This partnership strengthens our innovation pipeline and reinforces our role as a trusted global partner for biotech development.”

The financing round remains open to other strategic investors who share Alveolus Bio’s vision of transforming respiratory medicine.

About Shilpa Medicare
Shilpa Medicare is a global pharmaceutical company with capabilities across drug discovery to commercialization, specializing in respiratory therapeutics and biotech innovation. Visit www.vbshilpa.com.

About Alveolus Bio
A Biostack Ventures company, Alveolus Bio is developing first-in-class therapies for lung diseases using its proprietary resMIT platform. Its pipeline includes programs for COPD, BPD, Pulmonary Fibrosis, Cystic Fibrosis, and more.

 

Amorepacific Museum of Art Presents Mark Bradford: Keep Walking

First Major Solo Exhibition in Korea by Mark Bradford to Open at Amorepacific Museum of Art
Pioneer of ‘Social Abstraction’ Unveiled in Landmark Exhibition in Seoul

SEOUL, South Korea, Aug. 4, 2025 /PRNewswire/ — Amorepacific Museum of Art (Director: Seungchang Jeon) is proud to present Mark Bradford: Keep Walking, the first solo exhibition in South Korea by the internationally acclaimed American artist Mark Bradford. This landmark exhibition is also the largest presentation of Bradford’s work in Asia, offering an expansive overview of his artistic practice spanning more than two decades.

Amorepacific Museum of Art ‘Mark Bradford: Keep Walking’ Exhibition Poster
Amorepacific Museum of Art ‘Mark Bradford: Keep Walking’ Exhibition Poster

 

Amorepacific Museum of Art Mark Bradford: Keep Walking Exhibition Gallery
Amorepacific Museum of Art Mark Bradford: Keep Walking Exhibition Gallery

 

Amorepacific Museum of Art Mark Bradford: Keep Walking Exhibition Gallery
Amorepacific Museum of Art Mark Bradford: Keep Walking Exhibition Gallery

Born in 1961 in South Central Los Angeles, Bradford is known for his monumental abstract paintings that interweave personal history with broader social narratives. Drawing from his autobiographical experiences and from his deep ties to his local community, Bradford creates layered, tactile compositions using materials scavenged from the urban environment – billboard paper, flyers, endpapers from beauty salons, and fragments of everyday life. Through a process of building up, sanding down, tearing, and collaging, he transforms the detritus of the city into poetic and politically resonant works.

Bradford refers to his visual language as “Social Abstraction” – a practice that retains the formal strategies of abstraction while engaging directly with issues of race, gender, class, and the systems of power that shape contemporary society. His work has been widely celebrated across the globe, including representing the United States at the 2017 Venice Biennale. He was named one of Time magazine’s 100 Most Influential People in 2021 and ranked 19th on ArtReview’s Power 100 in 2024.

Keep Walking brings together approximately 40 works—including large-scale paintings, video installations, and newly commissioned pieces developed specifically for the museum’s architecture. Featured works include early seminal paintings such as Blue (2005) and Niagara (2005), the latter inspired by the eponymous 1953 film starring Marilyn Monroe. Also on view is Float (2019), a monumental floor installation that invites viewers to physically walk across its surface, experiencing the artwork through movement and proximity.

Visitors will encounter the visual and emotional weight of Bradford’s compositions—dense fields of color, texture, and meaning that reflect the turbulence and resilience of contemporary life. These works do not merely illustrate social conditions; they embody them through material and process. The exhibition offers a rare opportunity to engage with one of today’s most powerful voices in contemporary painting.

This presentation is part of an international touring exhibition organized by Hamburger Bahnhof – Nationalgalerie der Gegenwart in Berlin. The Seoul presentation expands upon the earlier iteration, incorporating new works and a site-responsive approach tailored to the distinctive architecture of Amorepacific Museum of Art.

Mark Bradford has redefined what painting can be – not just as a formal exercise, but as a space where histories, identities, and communities collide and coalesce,” said Amorepacific Museum of Art. “Through this exhibition, we hope to offer Korean audiences a profound and immersive experience of Bradford’s artistic vision and his ongoing exploration of abstraction as a deeply social medium.”

###

[Exhibition Overview]

  • Title: Mark Bradford: Keep Walking
  • Dates: August 1, 2025 (FRI) through January 25, 2026 (SUN)
  •  Opening Hours: 10 AM to 6 PM (Closed on Mondays, January 1, Seollal and Chuseok holidays)
  • Venue: Amorepacific Museum of Art (100, Hangang-daero, Yongsan-gu, Seoul, South Korea)
  • Admission: APMA website: http://apma.amorepacific.com
  • Exhibition Support: Sulwhasoo

Treasury and Payments Platform Finmo Enhances Transaction Security with Confirmation of Payee Rollout in Australia

SYDNEY and SINGAPORE, Aug. 4, 2025 /PRNewswire/ — Finmo, a Treasury and Payments platform solving for speed, security, and control in modern finance, has officially gone live with Confirmation of Payee (CoP) in Australia, reinforcing its commitment to fraud prevention, regulatory readiness, and customer trust.

As the country begins its industry-wide CoP rollout, Finmo is among the first payment platforms to adopt the safeguard. Mandated by Australian Payments Plus (AP+) and supported by the New Payments Platform (NPP), CoP helps tackle rising fraud by verifying account details before funds are sent. It also helps prevent supplier fraud, misrouted payments, and delays in reconciliation, offering businesses greater confidence and control over every transaction.

Anthony Yeoh, Chief Compliance Officer of Finmo said, “Being among the first to implement CoP reflects Finmo’s proactive approach to compliance, risk and fraud management. It’s not just about meeting regulatory expectations; it’s about building trust into the foundation of every transaction. With global operations in multiple jurisdictions and partnerships across the financial ecosystem, we’re taking meaningful steps towards ensuring a safer global payments landscape.”

Finmo’s CoP integration is powered by Australian Settlements Limited (ASL), a Tier 1 NPP participant. This real-time connectivity allows Finmo to validate recipient details at the point of initiation, closing a gap in the payment lifecycle. CoP verifies the account name, number, and BSB – a six-digit code identifying the recipient’s bank and branch in Australia – before a payment is processed.

Akhil Nigam, Chief Product Officer and Co-founder of Finmo explained, “CoP is more than a compliance feature, it’s a powerful safety net that gives finance teams greater control and confidence. By automatically verifying payment details before money leaves your account, we’re helping shift fraud prevention from reactive to proactive, embedding trust into the very fabric of every transaction.”

Adrian Lovney, Chief Payments and Schemes Officer of AP+ said, “Confirmation of Payee is all about giving customers greater control and confidence when making payments. It’s a simple concept, but it adds a powerful extra layer of protection for everyday transactions.”

Mark Tibbles, Chief Executive Officer of ASL said, “We’re proud to support Finmo in delivering real-time Confirmation of Payee in the initial phase of market rollout. Moving quickly to bring this feature to Finmo users improves network safety and builds trust for businesses and consumers alike.”

This milestone builds on Finmo’s regulatory momentum, following its approval as a UK Electronic Money Institution (EMI) in July 2025. The licence authorises Finmo to issue e-money, provide domestic and cross-border payments, and offer FX services, while enabling direct access to UK clearing systems and the ability to issue IBANs and safeguard client funds locally. The UK EMI licence complements Finmo’s existing approval in Singapore, Australia, New Zealand, Canada, United States, and UK.

New Reeracoen × Rakuten Insight APAC Study Finds Singapore Ahead in Flexibility and ESG as Workforce Expectations Are Rising Across the Region.

SINGAPORE, Aug. 4, 2025 /PRNewswire/ — As workforce expectations continue to evolve across Asia-Pacific in 2025, a significant new study by recruitment firm Reeracoen and research agency Rakuten Insight Global positions Singapore as a regional leader in workplace flexibility and sustainability-driven employment. At the same time, the study reveals emerging gaps between what talent expects and what employers are prepared to offer, both regionally and locally.  

The Reeracoen × Rakuten Insight APAC Workforce Whitepaper 2025 draws on insights from more than 12,000 professionals across 12 Asia-Pacific economies. It outlines how workers are prioritising hybrid work, values-led employment, and continuous development, even as companies slow hiring and recalibrate productivity targets.

“Across APAC, we are seeing a structural reset in what people want from work,” said Kenji Naito, Group CEO of Reeracoen. “Flexibility, purpose, and learning are no longer perks. They are expectations. Singapore is ahead of the curve on many of these fronts and offers a powerful case study for the region.”

Mr. Kenji Naito, Group Chief Executive Officer, Reeracoen Group
Mr. Kenji Naito, Group Chief Executive Officer, Reeracoen Group

Key Findings from Across APAC:

  • “Flexibility Gap”: 72% of workers want hybrid work models, but only 46% currently have access. Singapore and Vietnam lead in flexibility, while Japan and South Korea lag.
  • Purpose Matters: 71% of APAC respondents say a company’s sustainability and CSR initiatives influence their choice of employer. This rises to 82% in Vietnam and 79% in Singapore but drops to 48% in Japan.
  • Learning is Essential: 65% cite skills development as their top career driver, but only 18% say their current employer leads that process, revealing a growing “learning leadership” gap.
  • Mobility Rising: One in three APAC workers is open to overseas relocation. In Singapore, 43% are open to it; this is less than in Vietnam (62%) but more than in Japan (9%).
  • Salary Expectations Are Rising: While employers face macroeconomic caution, 28% of APAC workers still expect salary increases exceeding 10%.

Spotlight on Singapore

  • Hybrid Work Access: Singapore ranks first among APAC markets, with 68% of workers offering hybrid work, more than 20 points above the regional average.
  • Values Influence Job Choice: 79% of Singaporeans consider a company’s CSR and ESG efforts when deciding where to work, placing Singapore among the top-ranked markets for value-driven employment.
  • Local Over Global Mobility: Only 43% of Singaporeans are open to relocating abroad, reflecting a preference for domestic opportunities with progressive work environments.
  • Top Motivators: Salary (82%), skill development (67%), and work-life balance (61%) remain the leading career drivers.

While sectors like technology and finance continue to dominate white-collar hiring, employers in Singapore are shifting toward leaner teams, more precise productivity targets, and a growing emphasis on cultural fit. The report urges companies to balance cost discipline with workforce expectations to maintain long-term competitiveness.

“Sustainable practices and purpose-led work cultures are no longer optional,” said Shoichi Sunaga, Branch Manager of Reeracoen Singapore. “Today’s candidates are actively screening for them.”

Mr. Shoichi Sunaga, Branch Manager, Reeracoen Singapore
Mr. Shoichi Sunaga, Branch Manager, Reeracoen Singapore

“In today’s rapidly evolving job market, leveraging insights to understand what truly drives talent is not just beneficial, it’s a non-negotiable competitive advantage,” said Cheryl Ng, Country Director, Singapore at Rakuten Insight. “Such critical shifts shaping the future of work inform us how to balance cost efficiency while upholding core values and successfully attracting and retaining key talent.”

About the Study

The whitepaper synthesises insights from over 12,000 respondents across the APAC region, including Singapore. It provides both regional analysis and market-specific breakdowns to support workforce benchmarking and strategic planning.

About Reeracoen Singapore Pte Ltd

Reeracoen is an award-winning leader in Asia’s recruitment landscape, celebrated for connecting top-tier talent with forward-thinking organisations. With a strong presence across the region, we leverage our expansive networks and deep industry expertise to deliver innovative recruitment solutions tailored to the evolving needs of our partners.

Operating across nine offices in six major Asian countries, Reeracoen upholds the highest standards of professionalism and service excellence. Our accolades and proven track record underscore our commitment to providing exceptional service quality and cross-border talent solutions, making us the preferred recruitment partner for businesses looking to thrive in the dynamic Asian market.

For more information, visit https://www.reeracoen.sg and follow us on LinkedIn for the latest updates and insights.

QBE Automotive Protection: Cars in the Philippines kept pristine for longer with new insurance product

  • Small and Medium Repair Technology (“SMART”) Protect will be available to car dealerships and manufacturers in the Philippines to better protect their customers from dings and dents.

MANILA, Philippines, Aug. 4, 2025 /PRNewswire/ — A new automotive protection product is now available to car dealerships and manufacturers to better protect their customers from dings and dents. 

The product: Small and Medium Repair Technology (“SMART”) Protect means car dealerships can offer their customers cover for accidental damages caused by everyday driving. 

SMART Protect available from QBE Automotive Protection is a type of car insurance coverage that helps pay for repairs to minor cosmetic damage, like small dents or scratches. 

The product typically covers door dings, or small bumps and scratches that do not affect the overall function of the vehicle but can still be annoying and lower its appearance or value.  

Albert Chow, General Manager of QBE Automotive Protection, Asia, stated, “Building on our successful launch of SMART protect elsewhere in the Asia region, we are delighted to offer SMART to automotive OEMs, distributors and dealers in the Philippines through our partner Paramount Life and General Insurance Corporation,” he said.   

“Vehicle owners in the Philippines will be able to purchase a car and know they can get small aesthetic fixes carried out whenever they need it. SMART Protect aims to offer fair value and is backed by a large financial institution.”

Many Filipinos hold onto their cars for extended periods compared to other markets, often for more than five years, and so this product is particularly appealing for these people who want to diligently maintain their vehicle while holding on to it for longer[1]

In addition, the car market in the Philippines has been experiencing significant growth in recent years. 

According to a joint report from the Chamber Automotive Manufacturers of the Philippines, Inc. (CAMPI) and the Truck Manufacturers Association (TMA), vehicle sales accelerated at the beginning of 2025, showing a 10.4% year-on-year increase, leading to 37,604 units of vehicles sold. With such growth, the industry has projected an overall 8% rise in vehicle sales, aiming for 512,000 sold units in 2025[2]

QBE Automotive Protection has protected millions of customer vehicles over 26 years in 36 countries around the world. The QBE business has been operating in the Philippines since 2016 and in Asia for 20 years. 

Key features of SMART Protect include: 

  • The product has been approved by the regulator
  • There are no deductibles
  • You do not need to have had an accident to claim this
  • You take your car back to the dealership for repairs

More information: https://qbeautomotiveprotection.com. The product is available via Paramount Life & General Insurance Corporation.

About QBE Asia

QBE Asia is part of the International Division of QBE Insurance Group Limited. Headquartered in Sydney, QBE is listed on the Australia Securities Exchange (ASX). To learn more about QBE Insurance Group, please visit www.qbe.com.